233 related articles for article (PubMed ID: 26370678)
1. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
[TBL] [Abstract][Full Text] [Related]
5. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
Harris PE; Farwell MD; Ichise M
Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
[TBL] [Abstract][Full Text] [Related]
6. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
[TBL] [Abstract][Full Text] [Related]
7. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
[TBL] [Abstract][Full Text] [Related]
8. Deuterated
Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.
Normandin MD; Petersen KF; Ding YS; Lin SF; Naik S; Fowles K; Skovronsky DM; Herold KC; McCarthy TJ; Calle RA; Carson RE; Treadway JL; Cline GW
J Nucl Med; 2012 Jun; 53(6):908-16. PubMed ID: 22573821
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
Li J; Chen P; Bao Y; Sun Y; He J; Liu X
Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
Souza F; Simpson N; Raffo A; Saxena C; Maffei A; Hardy M; Kilbourn M; Goland R; Leibel R; Mann JJ; Van Heertum R; Harris PE
J Clin Invest; 2006 Jun; 116(6):1506-13. PubMed ID: 16710474
[TBL] [Abstract][Full Text] [Related]
13. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
[TBL] [Abstract][Full Text] [Related]
14. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
[TBL] [Abstract][Full Text] [Related]
15. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [
Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X
Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623
[TBL] [Abstract][Full Text] [Related]
16. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H
Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872
[TBL] [Abstract][Full Text] [Related]
17. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
[TBL] [Abstract][Full Text] [Related]
18. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
[TBL] [Abstract][Full Text] [Related]
19. Visualizing pancreatic beta-cell mass with [11C]DTBZ.
Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE
Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.
Eriksson O; Jahan M; Johnström P; Korsgren O; Sundin A; Halldin C; Johansson L
Nucl Med Biol; 2010 Apr; 37(3):357-63. PubMed ID: 20346875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
